Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (64)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- Marfan syndrome is a systemic connective-tissue disorder
- Microfibrils provide the scaffold for elastic fibers
- FBN2-related disease is a useful molecular contrast
- The two pathways are complementary rather than competing
- Craniofacial findings can support phenotype recognition
- Clinical priority follows the consequences, not frequency alone
- A diagnostic assessment requires separate organ-system observations
- Clinical synthesis: Recognize and prioritize
Slide index & full transcript (64 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Marfan syndrome
Molecular pathogenesis · Morphology · Clinicopathologic correlation
Fibrillin-1
Extracellular microfibrils
TGF-β
Signaling dysregulation
Aorta
Life-threatening injury
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Explain FBN1-associated autosomal dominant disease
Distinguish structural and signaling mechanisms
Correlate the pathogenesis with organ-system findings
Recognize why aortic assessment is central
Organize every manifestation around the underlying extracellular-matrix defect.
Slide 3 · Marfan syndrome is a systemic connective-tissue disorder
Skeleton
Growth and ligament findings
Eyes
Lens-support abnormality
Cardiovascular
Aorta and cardiac valves
The skeleton, eyes, and cardiovascular system are prominently affected
A single molecular defect can produce disparate organ-level phenotypes
Aortic disease determines much of the life-threatening risk
Slide 4 · The multisystem pattern is more informative than body habitus alone
Systemic ECM defect
Variable organ involvement
Integrated assessment
Marked skeletal manifestations are not necessary in every affected patient
Cardiovascular or ocular manifestations may predominate
Clinical evaluation must not stop at tall stature
Schematic — causal sequence
Slide 5 · Aortic disease carries the greatest clinical hazard
Feature
Clinical interpretation
Valve manifestations
Often detectable; may produce regurgitation
Aortic involvement
Threatens the integrity of the arterial wall
Cardiac valve abnormalities may be frequent
The aortic complications are more clinically consequential
Slide 6 · Prevalence is approximately 1 in 5,000
This is the estimate reported by the source textbook
The condition is uncommon yet important as a cause of inherited aortopathy
The estimate describes population prevalence, not individual diagnostic probability
Epidemiologic prevalence cannot establish or exclude disease in an individual.
Slide 7 · Most cases are familial
Affected parent
Heterozygous transmission
Potentially affected offspring
Approximately 75% of cases are described as familial
Marfan syndrome follows autosomal dominant inheritance
Unaffected relatives do not exclude a de novo pathogenic variant
Schematic — causal sequence
Slide 8 · De novo FBN1 variants account for sporadic presentations
New pathogenic variant
Affected index patient
No preceding family phenotype required
The source attributes the remaining cases to new mutations
A negative reported family history is therefore not exclusionary
A patient with no affected parent can still have an inherited structural-protein disorder
Schematic — causal sequence
Slide 9 · Autosomal dominant transmission affects both sexes
Family-history concept
Implication
Vertical transmission
Supports autosomal dominant inheritance
No affected parent
Compatible with a de novo variant
Affected heterozygote
50% transmission risk per pregnancy
One heterozygous pathogenic variant can produce the phenotype
Both males and females can be affected and transmit the variant
Slide 10 · Connective tissue functions as an extracellular load-bearing system
Extracellular structural proteins
Resilience during stretch/recoil
Tissue integrity
Matrix proteins provide tensile support and resilience
Tissues exposed to stretching and recoil depend on intact fiber networks
A matrix defect may have both mechanical and signaling consequences
Schematic — causal sequence
Slide 11 · Fibrillin-1 is an extracellular microfibrillar glycoprotein
Fibrillin-1 molecules
Microfibril assemblies
ECM organization
Fibrillin-1 is a major constituent of matrix microfibrils
Microfibrils form organized assemblies in connective tissues
Abnormal fibrillin alters microfibril formation or abundance
Schematic — causal sequence
Slide 12 · Microfibrils provide the scaffold for elastic fibers
Microfibril scaffold
Tropoelastin deposition
Elastic-fiber network
Microfibril bundles are laid down in the extracellular matrix
Tropoelastin is deposited on that framework
The resulting elastic-fiber architecture supports deformability and recoil
Schematic — stages or conceptual sequence
Slide 13 · Elastic-fiber integrity matters most where tissues repeatedly stretch
Aorta
Cyclic vessel-wall strain
Ligaments
Joint stabilization
Zonules
Lens suspension
The aorta is exposed to pulsatile mechanical stress
Ligaments stabilize joints under movement
Ciliary zonules suspend the crystalline lens
Slide 14 · Fibrillin-1 and fibrillin-2 are distinct homologues
Gene
Protein
Source-linked disorder
FBN1
Fibrillin-1
Marfan syndrome
FBN2
Fibrillin-2
Congenital contractural arachnodactyly
FBN1 encodes fibrillin-1 on chromosome 15q21.1
FBN2 encodes fibrillin-2 on chromosome 5q23.31
Slide 15 · FBN1 is the principal Marfan syndrome locus
FBN1 variant
Altered fibrillin-1
Matrix dysfunction
Multisystem phenotype
Mutations in FBN1 are associated with the classic disorder
The encoded protein is part of the extracellular microfibril network
Gene–protein–matrix–organ relationships provide a unifying explanation
Schematic — causal sequence
Slide 16 · FBN1 variants are highly heterogeneous
Close to 1,000 distinct identified mutations
A single disorder arises from many different molecular alterations
Sequence heterogeneity contributes to phenotypic heterogeneity
Do not equate a single named variant with the entire clinical syndrome.
Slide 17 · Missense variants may exert dominant-negative effects
Missense FBN1 variant
Abnormal fibrillin-1
Impaired microfibril assembly
Weaker matrix
Abnormal fibrillin-1 can disrupt fiber polymerization
Mutant protein interferes with formation of a functional assembly
One altered allele therefore compromises matrix structure
Schematic — causal sequence
Slide 18 · Haploinsufficiency is a second mechanism
Reduced fibrillin-1 output
Subthreshold functional protein
Microfibril insufficiency
Some variants reduce effective fibrillin-1 abundance
The remaining allele does not supply sufficient functional protein
The source assigns approximately 10–15% of cases to this category
Schematic — causal sequence
Slide 19 · Dominant-negative and haploinsufficient defects differ
Feature
Dominant negative
Haploinsufficiency
Primary defect
Abnormal protein disrupts assembly
Insufficient functional protein
Common result
Compromised microfibrils
Compromised microfibrils
Both converge on reduced effective extracellular support
One mechanism disrupts assembly; The other lowers protein abundance
Slide 20 · FBN2-related disease is a useful molecular contrast
FBN2 variants are associated with congenital contractural arachnodactyly
It is described as an autosomal dominant skeletal condition
Similar fibrillin family membership does not imply identical phenotypes
The gene identity matters; Do not label every fibrillin-associated phenotype Marfan syndrome.
Slide 21 · Marfan pathogenesis has two converging mechanisms
Altered fibrillin-1
Weakened matrix support
Increased TGF-β signaling
Organ pathology
Loss of mechanical support in microfibril-rich matrix
Schematic — dual disease mechanisms
Slide 22 · Normal microfibrils mechanically reinforce connective tissue
Organized microfibrils
Elastic-fiber support
Resilient tissue
Fibrillin-rich assemblies integrate with elastic-fiber architecture
Elastic tissues withstand distortion and recover shape
Organ integrity depends on the organized extracellular network
Schematic — causal sequence
Slide 23 · Defective microfibrils weaken matrix-dependent tissues
Defective FBN1 product
Abnormal elastic scaffold
Loss of tissue support
Characteristic organ findings
Abnormal assembly disrupts the elastic-fiber framework
The aorta, ligaments, and lens zonules are particularly susceptible
Structural dysfunction explains several signature manifestations
Schematic — causal sequence
Slide 24 · Microfibrils also regulate TGF-β availability
Intact fibrillin-rich matrix
Extracellular TGF-β sequestration
Controlled growth-factor activity
Normal fibrillin-rich matrix sequesters TGF-β
Extracellular sequestration limits signaling availability
Microfibril dysfunction therefore perturbs growth-factor regulation
Schematic — causal sequence
Slide 25 · Altered fibrillin can increase TGF-β signaling
Microfibril defect
Reduced TGF-β sequestration
Excessive pathway activation
Reduced or abnormal microfibrils impair sequestration
More TGF-β becomes bioavailable to responsive cells
Growth-factor dysregulation is a second disease mechanism
Schematic — causal sequence
Slide 26 · Excessive TGF-β can disturb vascular smooth muscle biology
Excess TGF-β signaling
Abnormal smooth-muscle response
Vascular matrix vulnerability
The source links excess signaling to adverse smooth-muscle development
Altered cell–matrix interactions may impair vascular-wall homeostasis
This complements rather than replaces the structural explanation
Schematic — causal sequence
Slide 27 · Matrix metalloproteinases promote extracellular degradation
TGF-β overactivity
Higher MMP activity
ECM loss/remodeling
Further weakness
Excessive TGF-β signaling is linked to increased MMP activity
MMPs degrade extracellular-matrix components
Greater matrix turnover adds to structural weakness
Schematic — causal sequence
Slide 28 · TGF-β dysregulation explains features beyond reduced elasticity
Feature
Best emphasized pathway
Lens-zonule weakness
Structural support defect
Bone overgrowth
Signaling disturbance implicated
Myxoid valve change
Signaling disturbance implicated
Matrix weakness alone does not readily explain all disease effects
Bone overgrowth and myxoid mitral changes
Slide 29 · The two pathways are complementary rather than competing
Defective fibrillin-1
Mechanical support loss
TGF-β dysregulation
Combined tissue vulnerability
Mechanical effects weaken fibers and tissues
Schematic — dual disease mechanisms
Slide 30 · Related TGF-pathway variants can resemble Marfan aortopathy
The source describes disease associated with TGF-β type II receptor variants
It also describes TGFB3-associated inherited aortic predisposition
These observations support pathway involvement, not molecular identity with FBN1 disease
Distinct loci may converge on related aortic phenotypes; Preserve the genetic distinction.
Slide 31 · A single defect produces variable manifestations
Mechanical demand
Varies by organ
Signaling context
Varies by tissue
Molecular variant
Varies by patient
Different tissues depend on fibrillin-mediated support
TGF-β biology differs across the skeleton, valves, and vasculature
Mutation diversity contributes to variation among affected people
Slide 32 · Phenotypic variability is clinically important
Presentation
Important limitation
Striking body habitus
Does not prove ocular disease
Dominant ocular phenotype
May have few skeletal signs
Dominant cardiac phenotype
May have few skeletal signs
Some patients have striking skeletal changes
Others present with predominantly ocular or cardiovascular disease
Slide 33 · Skeletal manifestations are often the most visible
Body proportions
Long limbs and digits
Joint and spine
Laxity and curvature
Thorax
Anterior chest-wall deformity
The source identifies skeletal abnormalities as striking features
Typical findings concern height, proportions, joints, spine, and chest
They should be interpreted as part of a multisystem pattern
Slide 34 · Excess longitudinal growth alters body proportions
Many affected patients are unusually tall
Extremities can be disproportionately long
A tall body habitus is suggestive only in the right clinical context
Distinguish a characteristic habitus from a stand-alone diagnostic criterion.
Slide 35 · Arachnodactyly describes long, tapering digits
Altered skeletal growth
Long tapering digits
Arachnodactyly
Fingers and toes may be elongated and slender
This is a morphological description, not a specific genotype
Evaluate the finding alongside ocular and cardiovascular features
Schematic — causal sequence
Slide 36 · Ligamentous laxity contributes to abnormal joint movement
Weakened ligament support
Greater joint excursion
Hypermobility findings
The source describes lax ligaments in hands and feet
Some patients can hyperextend the thumb toward the wrist
Excessive mobility reflects reduced connective-tissue restraint
Schematic — causal sequence
Slide 37 · Craniofacial findings can support phenotype recognition
The source describes dolichocephaly
Frontal bossing and prominent supraorbital ridges are also described
These features are supplementary, not equivalent to aortic assessment
Craniofacial appearance is nonspecific without the systemic context.
Slide 38 · Spinal deformities reflect altered musculoskeletal support
Spinal change
Morphological description
Kyphosis
Excess sagittal curvature
Scoliosis
Lateral curvature
Rotational/slipping change
Altered vertebral alignment
Kyphosis and scoliosis can occur
Rotational or slipping changes of vertebrae are also described
Slide 39 · Chest-wall deformities are clinically recognizable
Deformity
Characteristic configuration
Pectus excavatum
Sunken anterior chest wall
Pectus carinatum
Protruding anterior chest wall
Pectus excavatum is a depressed-sternum deformity
Pectus carinatum produces anterior sternum prominence
Slide 40 · Skeletal findings do not predict the severity of aortic disease
Visible skeletal phenotype
Does not quantify aortic involvement
Separate cardiovascular assessment
Visible musculoskeletal changes may be extensive or subtle
The source emphasizes marked interpatient clinical variability
Cardiovascular assessment is necessary regardless of body habitus
Schematic — causal sequence
Slide 41 · Zonular weakness causes ectopia lentis
Zonular fibrillin defect
Loss of lens support
Ectopia lentis
The lens is suspended by circumferential ciliary zonules
Microfibrils are important for zonular tensile support
Weakening predisposes to lens subluxation or dislocation
Schematic — causal sequence
Slide 42 · Ectopia lentis is a particularly characteristic ocular finding
Dislocation or subluxation can be bilateral
Outward and upward displacement as typical
Bilateral ectopia lentis should prompt consideration of Marfan syndrome
The diagnostic implication lies in the distinctive ocular–systemic association.
Slide 43 · Lens displacement is a structural phenotype
Intact zonular support
Zonular weakness
Lens instability
Disrupted microfibrils weaken zonular attachments
The resulting mechanical instability displaces the crystalline lens
The ocular manifestation directly illustrates the support-defect pathway
Schematic — stages or conceptual sequence
Slide 44 · Aortic involvement is the major life-threatening manifestation
Weakened aortic matrix
Wall susceptibility
Dissection
Potential rupture
The aortic wall relies on elastic-fiber integrity
Extracellular-matrix dysregulation compromises vascular-wall resilience
Aortic dissection and rupture are the major feared outcomes described
Schematic — causal sequence
Slide 45 · Aortic dissection represents wall-layer separation
Aortic-wall weakness
Dissection
Possible rupture
The disease process involves compromised integrity of the aortic wall
Dissection creates a dangerous separation within the wall
Rupture of a dissection can cause catastrophic hemorrhage
Schematic — causal sequence
Slide 46 · Clinical priority follows the consequences, not frequency alone
Issue
Mitral involvement
Aortic involvement
Dominant consequence
Regurgitant valve dysfunction
Dissection and possible rupture
Priority
Function and symptoms
Life-threatening structural risk
Mitral lesions may be more frequent than some other abnormalities
Aortic lesions carry greater threat to life
Slide 47 · Loss of support makes mitral leaflets floppy
Mitral ECM support loss
Billowing / prolapse
Potential regurgitation
Matrix weakness produces soft, billowy leaflets
Mitral valve prolapse is a common cardiac finding
Changes may be accompanied by elongated chordae tendineae
Schematic — causal sequence
Slide 48 · Mitral valve prolapse may lead to regurgitation
Prolapse / chordal elongation
Imperfect closure
Mitral regurgitation
Abnormal leaflet movement interferes with normal closure
Chordal lengthening can aggravate impaired coaptation
Regurgitant flow is the major functional consequence described
Schematic — causal sequence
Slide 49 · Other cardiac valves may also be affected
Mitral valve
Frequent prolapse/regurgitation
Tricuspid valve
Similar changes possible
Aortic valve
Similar changes less common
The source reports similar changes in the tricuspid valve
Aortic valve involvement is described as rarer
Multivalvular findings reflect the systemic nature of matrix disease
Slide 50 · Echocardiography identifies cardiovascular manifestations
Suspected connective-tissue disease
Echocardiographic assessment
Document cardiac abnormalities
Its value in detecting cardiac abnormalities
Valvular structure and function can be assessed
Aortic and valve findings require direct evaluation rather than inference from appearance
Schematic — causal sequence
Slide 51 · Expression varies within and between families
Type of variability
Meaning
Intrafamilial
Different features among relatives
Interfamilial
Different patterns among families
Mutation heterogeneity
Plausible contributor to variation
The source describes variable manifestations within families
Differences between families may be more marked
Slide 52 · Absence of one organ-system sign cannot exclude disease
One positive clinical clue
Assess other affected systems
Avoid isolated-sign diagnosis
Ocular abnormalities may occur without a striking skeletal phenotype
Likewise, skeletal findings may be prominent without eye changes
The clinical assessment should deliberately survey multiple systems
Schematic — causal sequence
Slide 53 · Revised Ghent diagnosis integrates several evidence types
Family context
Inheritance history
Clinical findings
Aorta, lens and systemic signs
Molecular evidence
Relevant FBN1 variant
The source names family history, cardinal clinical features, and FBN1 status
Cardiovascular and ocular findings are particularly salient
The textbook excerpt is not a complete operational list of diagnostic rules
Slide 54 · A diagnostic assessment requires separate organ-system observations
Skeletal examination
Morphologic findings
Ophthalmic examination
Lens position
Cardiovascular assessment
Aortic and valve findings
Record skeletal features without equating them with diagnosis
Seek ocular features such as ectopia lentis
Determine cardiovascular abnormalities with appropriate clinical evaluation
Slide 55 · A gene result is interpreted alongside the phenotype
Observed FBN1 finding
Molecular interpretation
Multisystem phenotype correlation
FBN1 variants are diverse in molecular effect
The disease may involve dominant-negative action or haploinsufficiency
A molecular observation and a compatible clinical phenotype together are more informative
Schematic — causal sequence
Slide 56 · Marfan and Ehlers–Danlos syndromes target different matrix systems
Feature
Marfan syndrome
Ehlers–Danlos syndromes
Principal matrix defect
Fibrillin-1 / microfibrils
Collagen / collagen-related processes
Typical emphasis
Lens, skeleton and aorta
Skin, joints and tissue fragility
Marfan syndrome involves fibrillin-rich microfibrils
Ehlers–Danlos syndromes often involve collagen or collagen processing
Slide 57 · FBN2-associated contractural arachnodactyly is not Marfan syndrome
Disorder
Associated gene
Teaching distinction
Marfan syndrome
FBN1
Multisystem fibrillin-1 disorder
Congenital contractural arachnodactyly
FBN2
Related but distinct skeletal disorder
Both disorders affect proteins in the fibrillin family
The source assigns congenital contractural arachnodactyly to FBN2
Slide 58 · Case: Bilateral ectopia lentis with subtle skeletal changes
Finding: Bilateral ectopia lentis
A patient has bilateral lens displacement and few obvious skeletal signs
Which organ system must still be carefully assessed?
Answer: The cardiovascular system, particularly the aorta
Slide 59 · Case: Marked arachnodactyly without known family history
Finding: Skeletal pattern; No family history
A patient has long limbs, arachnodactyly, and chest-wall deformity
Does an unaffected family history rule out Marfan syndrome?
Answer: No; Sporadic de novo variants are described
Slide 60 · Case: Mitral prolapse should not end the evaluation
Finding: Mitral valve prolapse
A patient has mitral valve prolapse in a connective-tissue phenotype
What additional cardiovascular issue matters most?
Answer: Assess aortic involvement because of dissection risk
Slide 61 · Case: A genotype must be explained mechanistically
Molecular clue: Abnormal fibrillin-1 disrupts assembly
A variant produces abnormal fibrillin-1 that disrupts assembly
Which dominant molecular mechanism does this exemplify?
Answer: Dominant-negative interference with microfibril formation
Slide 62 · Mechanistic synthesis: Genotype to organ injury
FBN1-associated defect
Support failure
TGF-β excess
Multisystem clinical disease
FBN1 mutation produces abnormal quantity or quality of fibrillin-1
Schematic — dual disease mechanisms
Slide 63 · Clinical synthesis: Recognize and prioritize
Recognition
Eyes and skeletal pattern
Mechanism
Microfibrils and signaling
Priority
Aortic assessment
Ectopia lentis is a highly characteristic clue
Skeletal findings help recognize the phenotype but vary greatly
Aortic involvement is the central life-threatening concern
Slide 64 · References and source boundaries
Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th ed. (2026), Chapter 5, pp. 129–130
Adjacent parent context: “Autosomal Dominant Disorders,” Chapter 5
Adjacent Ehlers–Danlos section: comparison of extracellular-matrix disorders